XEL-1004

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameXEL-1004
Drug Alias NameXEL-1004
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell membrane modulatorsLipopolysaccharide (LPS) modulatorsCell wall inhibitors
TargetsLipopolysaccharide (LPS)
Therapy Area/IndicationsCystic FibrosisPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXellia Pharmaceuticals Aps
China Registration ClassN/A

Develop Information

Active CompaniesXellia Pharms
Inactive CompaniesN/A
Active IndicationsCystic FibrosisPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A